Resultats a la cerca d'autor

1

Getting a handle on hereditary CEBPA mutations per Courtney D. DiNardo

Publicat 2015

Obtenir text complet Obtenir text complet
Carta

Afegir a favorits

Guardat en:
2

Hereditary myeloid malignancies per Hind Rafei, Courtney D. DiNardo

Publicat 2019

Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
3

Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-12... per K.C. Birendra, Courtney D. DiNardo

Publicat 2016

Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
4

Hereditary Predispositions to Myelodysplastic Syndrome per Sarah A. Bannon, Courtney D. DiNardo

Publicat 2016

Obtenir text complet Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
5

Mutations in AML: prognostic and therapeutic implications per Courtney D. DiNardo, Jorge E. Cortés

Publicat 2016

Obtenir text complet Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
6

The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia per Iman Abou Dalle, Courtney D. DiNardo

Publicat 2018

Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
7

Advances in patient care through increasingly individualized therapy per Courtney D. DiNardo, Alexander E. Perl

Publicat 2019

Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
8

Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapy per Guillaume Richard‐Carpentier, Courtney D. DiNardo

Publicat 2019

Obtenir text complet Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
9

How I treat acute myeloid leukemia in the era of new drugs per Courtney D. DiNardo, Andrew H. Wei

Publicat 2019

Obtenir text complet Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
10

Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm per Ghayas C. Issa, Courtney D. DiNardo

Publicat 2021

Obtenir text complet Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
11

Venetoclax-based therapies for acute myeloid leukemia per Veronica Guerra, Courtney D. DiNardo, Marina Konopleva

Publicat 2019

Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
12

Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions per Bachar Samra, Marina Konopleva, Alessandro Isidori, Naval Daver, Courtney D. DiNardo

Publicat 2020

Obtenir text complet Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
13

Acute myeloid leukaemia per Courtney D. DiNardo, Harry P. Erba, Sylvie D. Freeman, Andrew H. Wei

Publicat 2023

Obtenir text complet Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
14

Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach per Hagop M. Kantarjian, Tapan M. Kadia, Courtney D. DiNardo, Mary Alma Welch, Farhad Ravandi

Publicat 2021

Obtenir text complet Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
15

New directions for emerging therapies in acute myeloid leukemia: the next chapter per Naval Daver, Andrew H. Wei, Daniel A. Pollyea, Amir T. Fathi, Paresh Vyas, Courtney D. DiNardo

Publicat 2020

Obtenir text complet Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
16

Resistance to targeted therapies: delving into FLT3 and IDH per Sai Prasad Desikan, Naval Daver, Courtney D. DiNardo, Tapan M. Kadia, Marina Konopleva, Farhad Ravandi

Publicat 2022

Obtenir text complet Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
17

Isocitrate dehydrogenase mutations in myeloid malignancies per Bruno C. Medeiros, Amir T. Fathi, Courtney D. DiNardo, Daniel A. Pollyea, Steven M. Chan, Ronan Swords

Publicat 2016

Obtenir text complet Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
18

EVI1 dysregulation: impact on biology and therapy of myeloid malignancies per Christine Birdwell, Warren Fiskus, Tapan M. Kadia, Courtney D. DiNardo, Christopher P. Mill, Kapil N. Bhalla

Publicat 2021

Obtenir text complet Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
19

Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges per Nicholas J. Short, Marina Konopleva, Tapan M. Kadia, Gautam Borthakur, Farhad Ravandi, Courtney D. DiNardo, Naval Daver

Publicat 2020

Obtenir text complet
Revisão

Afegir a favorits

Guardat en:
20

Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2 per Amir T. Fathi, Courtney D. DiNardo, Irina Kline, Laurie Kenvin, Ira Gupta, Eyal C. Attar, Eytan M. Stein, Stéphane de Botton

Publicat 2018

Obtenir text complet Obtenir text complet
Artigo

Afegir a favorits

Guardat en:

Resultats de la cerca - Courtney D. DiNardo

Getting a handle on hereditary CEBPA mutations per Courtney D. DiNardo

Hereditary myeloid malignancies per Hind Rafei, Courtney D. DiNardo

Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-12... per K.C. Birendra, Courtney D. DiNardo

Hereditary Predispositions to Myelodysplastic Syndrome per Sarah A. Bannon, Courtney D. DiNardo

Mutations in AML: prognostic and therapeutic implications per Courtney D. DiNardo, Jorge E. Cortés

The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia per Iman Abou Dalle, Courtney D. DiNardo

Advances in patient care through increasingly individualized therapy per Courtney D. DiNardo, Alexander E. Perl

Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapy per Guillaume Richard‐Carpentier, Courtney D. DiNardo

How I treat acute myeloid leukemia in the era of new drugs per Courtney D. DiNardo, Andrew H. Wei

Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm per Ghayas C. Issa, Courtney D. DiNardo

Venetoclax-based therapies for acute myeloid leukemia per Veronica Guerra, Courtney D. DiNardo, Marina Konopleva

Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions per Bachar Samra, Marina Konopleva, Alessandro Isidori, Naval Daver, Courtney D. DiNardo

Acute myeloid leukaemia per Courtney D. DiNardo, Harry P. Erba, Sylvie D. Freeman, Andrew H. Wei

Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach per Hagop M. Kantarjian, Tapan M. Kadia, Courtney D. DiNardo, Mary Alma Welch, Farhad Ravandi

New directions for emerging therapies in acute myeloid leukemia: the next chapter per Naval Daver, Andrew H. Wei, Daniel A. Pollyea, Amir T. Fathi, Paresh Vyas, Courtney D. DiNardo

Resistance to targeted therapies: delving into FLT3 and IDH per Sai Prasad Desikan, Naval Daver, Courtney D. DiNardo, Tapan M. Kadia, Marina Konopleva, Farhad Ravandi

Isocitrate dehydrogenase mutations in myeloid malignancies per Bruno C. Medeiros, Amir T. Fathi, Courtney D. DiNardo, Daniel A. Pollyea, Steven M. Chan, Ronan Swords

EVI1 dysregulation: impact on biology and therapy of myeloid malignancies per Christine Birdwell, Warren Fiskus, Tapan M. Kadia, Courtney D. DiNardo, Christopher P. Mill, Kapil N. Bhalla

Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges per Nicholas J. Short, Marina Konopleva, Tapan M. Kadia, Gautam Borthakur, Farhad Ravandi, Courtney D. DiNardo, Naval Daver

Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2 per Amir T. Fathi, Courtney D. DiNardo, Irina Kline, Laurie Kenvin, Ira Gupta, Eyal C. Attar, Eytan M. Stein, Stéphane de Botton

Eines de cerca:

Matèries relacionades